A single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou Chinese

European Journal of Human Genetics

Volumn 18, Issue 11, 2010, Pages 1255-1260

  Jiang, Chao Qiang ^a   Liu, Bin ^a   Cheung, Bernard M Y ^b   Lam, Tai Hing ^b   Lin, Jie Ming ^a   Li Jin, Ya ^a   Yue, Xiao Jun ^a   Ong, Kwok Leung ^b   Tam, Sidney ^c   Wong, Ka Sing ^d   Tomlinson, Brian ^d   Lam, Karen S L ^b   Thomas, G Neil ^e  

^a Guangzhou No 12 Hospital   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c QUEEN MARY HOSPITAL   (Hong Kong)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

apolipoproteins; hypertriglyceridaemia; single nucleotide polymorphisms; triglycerides

Indexed keywords

APOLIPOPROTEIN A5; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DRINKING BEHAVIOR; EDUCATIONAL STATUS; FEMALE; GENDER; GENE REPLICATION; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HAPLOTYPE MAP; HONG KONG; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; APOLIPOPROTEINS A; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HONG KONG; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; TRIGLYCERIDES;

EID: 77958468038     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.93     Document Type: Article

References (45)

1. Calandra S, Priore Oliva C, Tarugi P, Bertolini S: APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Curr Opin Lipidol 2006; 17: 122-127.
2. Charlton-Menys V, Durrington PN: Apolipoprotein A5 and hypertriglyceridemia. Clin Chem 2005; 51: 295-297.
3. Pennacchio LA, Olivier M, HubacekJA etal: An apolipoprotein influencingtriglycerides in humans and mice revealed by comparative sequencing. Science 2001; 294: 169-173.
4. Ishihara M, Kujiraoka T, Iwasaki T et al: A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. J Lipid Res 2005; 46: 2015-2022.
5. Yamada Y, Kato K, Hibino T et al: Prediction of genetic risk for metabolic syndrome. Atherosclerosis 2007; 191: 298-304. (Pubitemid 46400713)
6. Baum L, Tomlinson B, Thomas GN: APOA5-1131T>C polymorphism is associated with triglyceride levels in Chinese men. Clin Genet 2003; 63: 377-379.
7. Jiang C, Thomas GN, Lam TH et al: Cohort profile: The Guangzhou Biobank Cohort Study a Guangzhou-Hong Kong-Birmingham collaboration. Int J Epidemiol 2006; 35: 844-852. (Pubitemid 44540731)
8. Cheung BM, Wat NM, Man YB et al: Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care 2007; 30: 1430-1436.
9. Cheung BM, Wat NM, Tam S etal: Componentsof the metabolic syndrome predictiveof its development: a 6-year longitudinal study in Hong Kong Chinese. Clin Endocrinol (Oxf) 2008; 68: 730-737.
10. Cheung BM, Wat NM, Tso AW et al: Association between raised blood pressure and dysglycemia in Hong Kong Chinese. Diabetes Care 2008; 31: 1889-1891.
11. Yin P, J iang CQ, Cheng KK et al: Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet 2007; 370: 751-757.
12. Thomas GN, Lao XQ, Jiang CQ et al: Implications of increased weight and waist circumference on vascular risk in an older Chinese population: the Guangzhou Biobank Cohort Study. Atherosclerosis 2008; 196: 682-688.
13. Jiang CQ, Lao XQ, Yin P et al: Smoking, smoking cessation and aortic arch calcification in older Chinese: The Guangzhou Biobank Cohort Study. Atherosclerosis 2009; 202: 529-534.
14. JiangCQ, Lam TH, Lin JM etal: An overview of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort (GBCS-CVD): a platform for multidisciplinary colla-boration. J Hum Hypertens 2010; 24: 139-150.
15. The International HapMap Consortium: The International HapMap Project. Nature 2003; 426: 789-796.
16. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
17. Purcell S, Nea le B, Todd-Brown K etal: PLINK: a tool setfor whole-genomeassociation and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
18. Nyholt DR: A simple correction for multiple testing for single-nucleotide polymorph-isms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769.
19. Lai CQ, Tai ES, Tan CE et al: The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 2003; 44: 2365-2373.
20. Li GP, WangJY, Yan SK, Chen BS, Xue H, Wu G: Genetic effectof two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipopro-teins levels in a Chinese population. Clin Genet 2004; 65: 470-476.
21. Bi N, YanSK, Li GP, Yin ZN, Chen BS: Asingle nucleotidepolymorphism- 1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese. Mol Genet Metab 2004; 83: 280-286.
22. Liu H, ZhangS, Lin J etal: Association between DNA variant sites in theapolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism 2005; 54: 568-572.
23. TangYB, Sun P, Guo DP, LiXY, Chen Q, Fan LM: Association betweenapolipoprotein A5-1131T > C polymorphism and susceptibility of coronary artery disease in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005; 22: 281-283.
24. Chien KL, Fang WH, Wen HC et al: APOA1/C3/A5 haplotype and risk of hyper-triglyceridemia in Taiwanese. Clin Chim Acta 2008; 390: 56-62.
25. Hsu LA, Ko YL, Chang CJ, Teng MS, Wu S, Hu CF: Apolipoprotein A5 gene-1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Tawan. Clin Chem Lab Med 2008; 46: 1714-1719.
26. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC: Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet2002; 11: 3031-3038.
27. Szalai C, Keszei M, Duba J et al: Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 2004; 173: 109-114.
28. Elosua R, Ordovas JM, Cupples LA etal: Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study. J Lipid Res 2006; 47: 990-996.
29. Hodoglugil U, Tanyolaç S, Williamson DW, HuangY, Mahley RW: Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks. J Lipid Res 2006; 47: 144-153.
30. Lai CQ, Demissie S, Cupples LA et al: Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res 2004; 45: 2096-2105.
31. Havasi V, Szolnoki Z, Talian G et al: Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke. J Mol Neurosci 2006; 29: 177-183.
32. De Bakker PI, Burtt NP, Graham RR et al: Transferability of tag SNPs in genetic association studies in multiple populations. Nat Genet 2006; 38: 1298-1303.
33. Willer CJ, Sanna S, Jackson AU et al: Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008; 40: 161-169.
34. Grallert H, Sedlmeier EM, Huth C et al: APOA5 variants and metabolic syndrome in Caucasians. J Lipid Res 2007; 48: 2614-2621.
35. Komurcu-Bayrak E, Onat A, Poda M etal: Gender-modulated impact of apolipoprotein A5 gene (APOA5)-1131TC and c.56CG polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults. Clin Chem Lab Med 2008; 46: 778-784.
36. Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW: A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 2003;12: 2533-2539.
37. Tang Y, Sun P, Guo D etal: Agenetic variant c.553G > Tin theapolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis 2006; 185: 433-437.
38. Hsu LA, Ko YL, Chang CJ et al: Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 2006; 185: 143-149.
39. YamadaY, IchiharaS, KatoKetal:Geneticriskformetabolicsyndrome: examinationof candidate gene polymorphisms related to lipid metabolism in Japanese people. J Med Genet 2008; 45: 22-28.
40. Pullinger CR, Aouizerat BE, Movsesyan I et al: An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients. J Lipid Res 2008; 49: 1846-1854.
41. Liu Z, Hu M, Baum L, Thomas GN, Tomlinson B: Associationsof polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Atherosclerosis 2010; 208: 427-432.
42. Prieur X, Coste H, Rodriguez JC: The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element. J Biol Chem 2003; 278: 25468-25480.
43. Talmud PJ, Palmen J, Putt W, Lins L, HumphriesSE: Determination of the functionality of common APOA5 polymorphisms. J Biol Chem 2005; 280: 28215-28220.
44. Ahituv N, Akiyama J, Chapman-Helleboid A, Fruchart J, Pennacchio LA: In vivo characterization of human APOA5 haplotypes. Genomics 2007; 90: 674-679.
45. Patel A, Barzi F, Jamrozik K etal: Serum triglyceridesas a riskfactor for cardiovascular diseases in the Asia-Pacific region. Circulation 2004; 110: 2678-2686.